Literature DB >> 3548522

Pneumonia associated with the TWAR strain of Chlamydia.

T J Marrie, J T Grayston, S P Wang, C C Kuo.   

Abstract

From November 1981 to August 1984, 301 adult patients with community-acquired pneumonia were admitted to the major referral hospital of Nova Scotia. Serologic tests done on these patients included microimmunofluorescence using the TWAR strain of Chlamydia and all Chlamydia trachomatis serovars as antigens. The TWAR strain has been shown to cause mild pneumonia in teenagers and young adults. Of the 301 patients, 18 (6%) had serologic evidence of recent infection with the TWAR organism. Their mean age was 64 years. Pneumonia associated with the presence of acute TWAR antibody had no characteristic clinical or radiographic features when compared with pneumonia without acute chlamydia antibody. Six patients, who all had preexisting serious chronic disease, had severe illness, and 2 died. Both patients who died had complicated hospital courses and other concomitant infections. We conclude that the TWAR organism may cause pneumonia in older adults and persons with chronic diseases that require hospitalization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548522     DOI: 10.7326/0003-4819-106-4-507

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  51 in total

1.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia.

Authors:  Philippe Jaoude; Jessica Badlam; Anil Anandam; Ali A El-Solh
Journal:  Intern Emerg Med       Date:  2012-03-06       Impact factor: 3.397

Review 3.  Chlamydial infections.

Authors:  J Schachter
Journal:  West J Med       Date:  1990-11

4.  In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

Authors:  K Chirgwin; P M Roblin; M R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  Experimental infection with Chlamydia pneumoniae in nonhuman primates.

Authors:  S M Holland; H R Taylor; C A Gaydos; E W Kappus; T C Quinn
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 6.  Immunologic tests in the diagnosis of pulmonary infection.

Authors:  E Goldstein; J Koo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

7.  Antigenic and molecular analyses of different Chlamydia pneumoniae strains.

Authors:  C A Jantos; S Heck; R Roggendorf; M Sen-Gupta; J H Hegemann
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

8.  A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA.

Authors:  Y Kazuyama; S M Lee; K Amamiya; F Taguchi
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

9.  Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots.

Authors:  H M Freidank; A S Herr; E Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

10.  Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland.

Authors:  M R Ekman; M Leinonen; H Syrjälä; E Linnanmäki; P Kujala; P Saikku
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.